Literature DB >> 32255461

Self-sacrificial MOFs for ultra-long controlled release of bisphosphonate anti-osteoporotic drugs.

Maria Vassaki1, Konstantinos E Papathanasiou2, Chrystalleni Hadjicharalambous3, Daphne Chandrinou1, Petri Turhanen4, Duane Choquesillo-Lazarte5, Konstantinos D Demadis1.   

Abstract

In this paper we report drug delivery systems that are based on phosphonate MOFs. These employ biologically-acceptable metal ions (e.g. Ca2+ and Mg2+) and several anti-osteoporosis bisphosphonate drugs (etidronate, pamidronate, alendronate and neridronate), as the organic linkers. These materials have been synthesized, structurally characterized, and studied for the self-sacrificial release (by pH-driven dissolution) of the bisphosphonate active ingredient. They exhibit variable release rates and final % release, depending on the actual structure of the metal-bisphosphonate material. Their cytotoxicity profiles match those of the active ingredients.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32255461     DOI: 10.1039/d0cc00439a

Source DB:  PubMed          Journal:  Chem Commun (Camb)        ISSN: 1359-7345            Impact factor:   6.222


  2 in total

1.  Exploiting the Multifunctionality of M2+/Imidazole-Etidronates for Proton Conductivity (Zn2+) and Electrocatalysis (Co2+, Ni2+) toward the HER, OER, and ORR.

Authors:  Álvaro Vílchez-Cózar; Eirini Armakola; Maria Gjika; Aurelia Visa; Montse Bazaga-García; Pascual Olivera-Pastor; Duane Choquesillo-Lazarte; David Marrero-López; Aurelio Cabeza; Rosario M P Colodrero; Konstantinos D Demadis
Journal:  ACS Appl Mater Interfaces       Date:  2022-02-22       Impact factor: 9.229

2.  Drug-Inclusive Inorganic-Organic Hybrid Systems for the Controlled Release of the Osteoporosis Drug Zoledronate.

Authors:  Maria Vassaki; Savvina Lazarou; Petri Turhanen; Duane Choquesillo-Lazarte; Konstantinos D Demadis
Journal:  Molecules       Date:  2022-09-21       Impact factor: 4.927

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.